Abstract Ionizing radiation increases cell mortality in a dose-dependent manner. Increases in DNA double strand breaks, c-H2AX, p53 phophorylation, and protein levels of p53 and Bax also occur. We investigated the ability of ciprofloxacin (CIP), a widely prescribed antibiotic, to inhibit DNA damage induced by ionizing radiation. Human tumor TK6, NH32 (p53 2/2 of TK6) cells, and human normal peripheral blood mononuclear cells (PBMCs) were exposed to 2-8 Gy 60 Co-c-photon radiation. c-H2AX (an indicator of DNA strand breaks), phosphorylated p53 (responsible for cell-cycle arrest), Bcl-2 (an apoptotic protein, and cell death were measured. Ionizing irradiation increased c-H2AX amounts in TK6 cells (p53 ?/? ) within 1 h in a radiation dosedependent manner. CIP pretreatment and posttreatment effectively inhibited the increase in c-H2AX. CIP pretreatment reduced Bcl-2 production but promoted p53 phosphorylation, caspase-3 activation and cell death. In NH32 cells, CIP failed to significantly inhibit the radiation-induced c-H2AX increase, suggesting that CIP inhibition involves in p53-dependent mechanisms. In normal healthy human PBMCs, CIP failed to block the radiation-induced c-H2AX increase but effectively increased Bcl-2 production, but blocked the phospho-p53 increase and subsequent cell death.
Introduction
Ionizing irradiation is used to eliminate cancer cells while normal cells next to them are also exposed to it resulting in cell damage. Ionizing irradiation increases cell mortality in a dose-dependent manner [1] . Within 1 h after exposure, ionizing irradiation induces DNA double strand breaks (DSBs) that lead to ataxia-telangiectasia-mutated (ATM) phosphorylation. As a result, a histone variant H2AX is phosphorylated beginning within seconds, which is termed c-H2AX [2, 3] . c-H2AX accumulates at sites of DNA damage and form foci which can span mega-base regions [4] [5] [6] [7] . c-H2AX is frequently used as a DNA damage biomarker. The rate of DSB repair correlates with the rate of loss of c-H2AX foci [8] .
c-H2AX triggers the CHK2 signal transduction pathway that activates p53 and CDC25 [9] . DSB-induced phosphorylated ataxia-telangiectasia-mutated (ATM) can also directly phosphorylate p53 [9] . Phosphorylated p53 transcriptionally activates the CDK inhibitor p21 and arrests the cell cycle at G1/S [10] . The phosphorylated p53 also transcriptionally induces Gadd45a, and Bax. Four hours after irradiation, increases in protein levels of p53, p21, and Bax are found [11] . Bcl-2 was included in this study because of its anti-apoptotic capability [12] as opposed to Bax that is pro-apoptotic [13] .
Ciprofloxacin (CIP) is a FDA-approved drug for clinical use, a widely prescribed antimicrobial agent and a known topoisomerase-II inhibitor. It is very safe, even in high concentrations [14] . It is listed in the Strategic National Stockpile for emergency use against Bacillus anthracis and all US Food and Drug Administration requirements for human use of CIP have been fulfilled. In our previous work, we observed that CIP improved 30-day survival after irradiation followed by wound trauma, modulated cytokine profile in serum, and mitigated bone marrow damage and small intestinal injury in mice in addition to its capability of eliminating Gram-negative bacteria [15, 16] . The observation that CIP modulates cytokine levels is consistent with findings from other laboratories [17] . Furthermore, it is indicated that CIP has anti-proliferative activity in several cancer cell lines [18] . We, therefore, investigated in vitro the ability of CIP to inhibit DNA damage and subsequent protein responses induced by ionizing radiation in human blood cells. Herein, we report that gamma radiation significantly increased c-H2AX, p53 phosphorylation, p21, Bcl-2 in human tumor cells (TK6 cells), and normal healthy peripheral blood mononuclear cells (PBMCs). CIP treatment effectively inhibited c-H2AX and Bcl-2 production and promoted p53 phosphorylation, caspase-3 activation, and cell death in TK6 cells, while CIP treatment significantly increased Bcl-2 production and blocked p53 phosphorylation and cell death in human normal PBMCs.
Materials and methods

Drug
CIP was purchased from Sigma-Aldrich Co. (St. Louis, MO) and prepared in sterile water.
Cell culture
Human B lymphoblastoid cell line TK6 (p53 ?/? ) and human NH32 (p53 -/-of TK6 cells) were generous gifts from Dr. James Mitchell. Human PBMCs were purchased from AllCells (Emeryville, CA). Cells were grown in RPMI 1640 medium (Invitrogen, Carlsbad, CA) with 10 % fetal bovine serum (Invitrogen), 2 mM L-glutamine (Invitrogen), 100 U/ml penicillin, and 100 mg/ml streptomycin (Quality Biological Inc., Gaithersburg, MD) and maintained in a humidified 37°C incubator with continuous 5 % CO 2 supply. TK6 and NH32 cells were fed twice a week.
Irradiation
Cells were placed in 6-well plates and exposed to various doses of 60 Co gamma-photon radiation delivered at a dose rate of approximately 0.6 Gy/min. Dosimetry was performed using the alanine/electron paramagnetic resonance system. Calibration of the dose rate with alanine was traceable to the National Institute of Standards and Technology and the National Physics Laboratory of the United Kingdom. Sham-irradiated cells were exposed to the same treatments as irradiated cells, except for irradiation.
Cell viability
Cell viability was determined using the trypan blue dye exclusion assay [1] . A 10 ll volume of cell suspension was combined with 10 ll of 0.4 % trypan blue solution (Sigma Chemical Co., St Louis, MO), gently mixed, and allowed to stand for 5 min at room temperature. A 10 ll volume of the stained cell suspension was placed in a Countess TM cell counting chamber slides (Invitrogen, Eugene, Oregon) and the number of viable (unstained) and dead (stained) cells counted using a Countess TM automatic cell counter (Invitrogen).
Flow cytometry
Flow cytometry measured c-H2AX (an indicator of DNA strand breaks or implication of gene repair) and phosphorylated p53 on serine residue at position 15 (arrest cell cycle). About 10 5 cells were fixed in fixation buffer, washed, and stained with FITC-conjugated antibody against c-H2AX and PE-conjugated antibody against phosphorylated p53, using permeabilization buffer following the manufacturer's protocol (Millipore, Billerica, MA). Non-specific IgG was used as a control antibody. Stained cells were analyzed using a Guava EasyCyte MiNi flow cytometer and Guava software (Millipore).
Western blotting
To investigate levels of p53 phosphorylation, Gadd45a, Bax, p21, Bcl-2, caspase-3, IgG, and actin, cells were removed from the 6-well plates and pelleted by centrifugation at 7509g for 10 min. Cell pellets were resuspended in 100 lL Na 1 Hanks' solution containing protease inhibitors and sonicated. The total protein in the cell lysate was determined with Bio-Rad reagent (Bio-Rad, Richmond, CA, USA). Aliquots containing 20 lg of protein in Tris buffer (pH 6.8) containing 1 % sodium dodecyl sulfate (SDS) and 1 % 2-mercaptoethanol were resolved on SDS-polyacrylamide slab gels (Novex precast 4-20 % gel; Invitrogen). After electrophoresis, proteins were blotted onto a PVDF membrane (type NC, 0.45 lm; Invitrogen), using a Trans-Blot Ò Turbo TM Transfer System (Bio-Rad, Richmond, CA) and the manufacturer's protocol. After blocking the membrane by incubation in Tris-buffered saline-0.5 % tween20 (TBST) containing 3 % nonfat dried milk for 90 min at room temperature, the blot was incubated for 60 min at room temperature with antibodies directed to p53 phosphorylation, Gadd45a, Bax, p21, Bcl-2, actin (Santa Cruz Biotechnology), and caspase-3 (Epitomics, CA, USA) at a concentration of 1 lg/ml in TBST-3 % dried milk. The blot was then washed 3 times (10 min each) with TBST before incubating the blot for 60 min at room temperature with a 1,0009 dilution of species-specific IgG peroxidase conjugate (Santa Cruz Biotechnology) in TBST. The blot was washed 6 times (5 min each) in TBST before detection of peroxidase activity using the Enhanced Chemiluminenscence Plus (Amersham Life Science Inc., Arlington Heights, IL, USA). Actin and IgG levels were not altered by radiation; we, therefore, used them as controls for protein loading. Protein bands of interest were quantitated densitometrically and normalized to IgG or actin.
Immunofluorencent staining and confocal microscopic analyses of suspension cells
Cells harvested at specific time points were fixed in 10 % formalin. After fixation, cells were embedded first in HistoGel TM (Thermo Fisher Scientific Inc., Rockville, MD) according to the manufacturer's instruction, then in paraffin, and sectioned transversely. Unstained paraffin sections were used for immunofluorescent staining. Paraffin sections on slides were treated with Target Retrieval Solution and Protein Block Serum-Free (Dako North America, Inc., Carpinteria, CA) according to the manufacturer's instruction, and stained with anti-phospho-Histone H2A.X antibody (Cell Signaling Technology Ò , Danvers, MA) followed by Alexa Fluor Ò 647 Goat Anti-Rabbit IgG (Life Technologies Corporation, Grand Island, NY) antibody with washing between and after in phosphate-buffered saline (PBS) with 0.1 % Tween Ò 20. Resulting slides were briefly rinsed with PBS, desalted by dipping in distilleddeionized water, and sealed with coverslips in mounting medium with 4 0 ,6-diamidino-2-phenylindole (DAPI, Life Technologies Corporation, Grand Island, NY). A Zeiss LSM710 laser scanning confocal microscope (Carl Zeiss MicroImaging, Thornwood, NY) with an EC Plan-Neofluar 40x/0.75 objective was used to scan the signals.
Statistics
Data are presented as mean ± sem. One-way ANOVA, two-way ANOVA, studentized-range test, Bonferroni's inequality, and Student's t test were used for comparisons of groups with 5 % as a significant level.
Results
CIP inhibited gamma-photon radiation-induced c-H2AX
increases in TK6 cells, but not in PBMCs.
Because the rate of DSB repair correlates with the decreased number of c-H2AX foci [8] , c-H2AX formation was measured in TK6 cells using flow cytometry. As shown in Fig. 1 , radiation increased c-H2AX formation in a radiation dose-dependent manner. Because 8 Gy displayed a drastically increased c-H2AX formation, this radiation dose was used for the rest of experiments with TK6 cells. CIP pretreatment 24 h (Fig. 1b ) or 3 h (Fig. 2a) prior to irradiation inhibited c-H2AX formation (Fig. 1b) . CIP treatment 5 min or 30 min after irradiation also effectively inhibited the c-radiation-induced increases in c-H2AX formation in TK6 cells (Fig. 2b) . The radiation-induced c-H2AX formation increase was confirmed by c-H2AX foci using immunofluorescent stainings. The increase was effectively inhibited by CIP pretreatment (Fig. 2c) .
It is evident that radiation activates the p53 signal transduction pathway resulting in cell apoptosis in vitro [19] . p53 gene knockout cells display radio-resistance [11] . To determine whether CIP inhibition of radiation-induced c-H2AX formation was mediated by p53 protein, NH32 cells, a p53 gene knockout cell line, were irradiated in the presence or absence of CIP. Figure 3 depicts that radiation increased the c-H2AX formation that CIP was unable to significantly inhibit.
To see if human normal blood cells also responded to cirradiation like these tumor cells, human PBMCs were irradiated. Similar to TK6 cells, radiation increased the c-H2AX formation in human PBMCs (Fig. 4a) . However, CIP pretreatment 24 h prior to irradiation failed to inhibit c-H2AX formation (Fig. 4b) . The increased formation of c-H2AX after irradiation was confirmed by c-H2AX foci using the immunofluorescent staining. Unlike TK6 cells, the increase was not inhibited by CIP pretreatment in PBMCs (Fig. 4c) .
CIP potentiated gamma-irradiation-induced p53 phosphorylation, reduced Bcl-2 production and increased cell death in TK6 cells.
It is evident that radiation increases p53 phosphorylation [3, 11, 20] . To seek the effect of CIP on p53 phosphorylation using FacScan cytometry, TK6 cells were treated with CIP and analyzed by flow cytometric analysis. CIP pretreatment at 24 h or 3 h effectively potentiated p53 phosphorylation (Fig. 5a, b) , whereas CIP posttreatment at 10 min significantly inhibited p53 phosphorylation (Fig. 5c ). p53 phosphorylation was also observed using Western blot analysis (Fig. 5d, e) . CIP pretreatment also reduced Bcl-2 production in irradiated cells (Fig. 5d, e) .
Our laboratory has demonstrated that p53 -/-cells were resistant to radiation [19] and caspase-3 played a central role in apoptosis [1] . Therefore, caspase-3 activation was evaluated in CIP-pretreated cells. Figure 6a shows that irradiation decreased caspase-3 inactive form and increased its active form. This alteration was enhanced further by CIP. In irradiated cells, CIP upregulated p21 and Gadd45-a, but reduced Bax protein levels (Fig. 6a) .
Simultaneously, cell death was evaluated. We found that CIP sensitized cells to radiation-induced death in TK6 cells. CIP significantly rendered cell death in non-irradiated cells as well (Fig. 6b) .
CIP inhibited gamma-irradiation-induced p53 phosphorylation and increased Bcl-2 production and reduced cell death in PBMCs.
To seek the effect of CIP on p53 phosphorylation, PBMCs were treated with CIP and analyzed by flow cytometric analysis, PBMCs were treated with CIP 24 h at various doses prior to various doses of irradiation. Irradiation increased p53 phosphorylation in a dose-dependent manner. Unlike TK6 cells, Fig. 7a shows that CIP pretreatment alone slightly yet significantly increased p53 phosphorylation. However, CIP pretreatment at 50 and 200 lM in PBMCs significantly diminished the radiationinduced increase in p53 phosphorylation. Because 4 Gy produced a significant increase in p53 phosphorylation in PBMCs, 4 Gy was selected for the following experiments with PBMCs. The radiation-induced in p53 phosphorylation and CIP inhibition on this increase were confirmed by Western blotting analysis (Fig. 7b, c) . Radiation significantly increased Bcl-2 levels. In the presence of CIP, Bcl-2 protein level was further increased (Fig. 7b, c) .
We next looked at the levels of several proteins whose exposures were regulated by phosphorylated p53. CIP pretreatment increased p21, Gadd45-a, and Bax but not caspase-3 in irradiated PBMCs (Fig. 8a) . Because PBMCs were non-dividing cells, they died quickly after few days and became difficult to collect sufficient numbers of viable cells. Therefore, we measured cell viability only 1 and 24 h after irradiation. Figure 8b shows that the radiationinduced increase in cell death was also attenuated by CIP.
Discussion
CIP, a fluoroquinolone antibiotic, is well known and widely prescribed to treat a variety of bacterial infections. Research into CIP led to the discovery of its immunomodulatory properties. Several laboratories reported that CIP exerts immunomodulatory effects in rodent models and human clinical trials [21, 22] , improving a wide spectrum of conditions including thrombocytopenia [23] [24] [25] , Crohn's disease [26, 27] , rheumatoid arthritis [28, 29] and chemotherapy-induced neutropenia [30] . These favorable improvements are unrelated to its antimicrobial activity, but rather are ascribed to two general immunomodulatory actions that fluoroquinolones may share: stimulation of hematopoiesis by enhanced IL-3 and GM-CSF production [15, 31, 32] and reduction of inflammation mediated by IL-1, IL-6, and TNF-a [8, 15] .
In addition to the immunomodulatory properties of CIP, CIP displays anti-neoplastic activity in many cancer cell lines [18] . It is reported that CIP inhibited the ability of Metnase not only to cleave DNA but also to repair DNA [33] , because Metnase is in a complex with topopolymerase II and strongly enhances topopolymerase II activity [34] . We, herein, report that CIP pretreatment effectively inhibited radiation-induced increases in c-H2AX formation, but promoted p53 phosphorylation, reduced Bcl-2 production, and increased cell death in TK6 cells. The observation of CIP inhibition on the radiation-induced increases in c-H2AX formation is not consistent with the report with A549 human carcinoma cells [33] . The discrepancy can be due to different types of cells and different means of inducing c-H2AX formation. Nevertheless, the CIP enhancement on TK6 cell death is in agreement with other laboratories [18, 35] . A significant decrease in Bcl-2 levels was observed in irradiated cells pretreated with CIP, suggesting that the CIP enhancement of TK6 cell death is mediated by the inhibition of Bcl-2. Despite CIP pretreatment inhibiting DNA strand breaks caused by irradiation in TK6 cells, CIP-induced the p53 activation accompanied with the Bcl-2 inhibition, which might be a significant mechanism that led to increased cell death.
In contrast to what was found in TK6 cells, in normal human PBMCs, CIP did not alter the radiation-induced c-H2AX formation. It is elusive why CIP exerts its action differently between normal healthy cells and tumor cells. It is possible that activities, structures or interactions between Metnase and topopolymerase II in these two types of cells are distinct, which requires further studies to unfold the unknown. CIP significantly reduced p53 phosphorylation and increased Bcl-2 levels. CIP also increased subsequent Gadd45a, Bax, and p21 levels. The latter indeed is important for inhibiting CDK2/Cyclin-A/E to suppress induction of extra centrosomes after irradiation [36] . It has been demonstrated that p53 phosphorylation increases apoptosis [37, 38] . Nevertheless, it is evident that ionizing radiation induces apoptosis via both p53-dependent and p53-independent mechanisms [39, 40] . More importantly, p53 phosphorylation can occur in either the presence or the absence of ATM [41] . Therefore, we measured only p53 phosphorylation instead of ATM phosphorylation. We have reported that NH32 cells (the p53 -/-cells) were less sensitive to ionizing radiation resulting in attenuation of mortality [42] , suggesting that the p53-dependent apoptosis is absent in NH32 cells. Inhibition of p53 phosphorylation, stimulation of Bcl-2 protein amount, and reduced cell death after irradiation in CIP-treated cells suggest that CIP may This laboratory has reported that CIP significantly increased in vivo survival, altered the serum cytokine and chemokine profile, accelerated bone marrow recovery, attenuated ileal cell death, and prevented systemic bacterial Veh ? 4 Gy infection in irradiated mice followed by skin-wound trauma [15, 16] . These effects could be mediated by its capability to inhibit NF-jB and caspase-3 [14] . The pharmacokinetics [43] and pharmacodynamics [44] of CIP in humans have been well documented. CIP is well tolerated, distributes rapidly in tissues, and has similar half-lives in mice [45] [46] [47] and humans [43] . The CIP efficacy on survival improvement in a combined injury model of radiation and wound was not observed with amoxicillin or levofloxacin treatment [48] , suggesting the specificity of CIP. The in vitro human cell data from this report, together with above in vivo mouse results [15] , suggest that CIP may prove to be beneficial for treating critical sequelae of ionizing irradiation beginning at the step of p53 by the inhibition of p53 phosphorylation. CIP offers several advantages supporting the idea of further development as a drug to treat radiation-associated injuries: (1) it is included in the Strategic National Stockpile for bacterial infection control; (2) it can be taken orally enabling patients to self-administer; (3) it possesses not only antimicrobial but also favorable immunomodulatory activity; and (4) it is inexpensive.
In summary, CIP pretreatment significantly inhibited radiation-induced increases in c-H2AX formation, but promoted p53 phosphorylation and inhibited Bcl-2 levels in TK6 cells. CIP posttreatment inhibited the first two parameters. CIP pretreatment elevated the subsequent cell death. In human normal PBMCs, CIP pretreatment failed to inhibit radiation-induced increases in c-H2AX formation, but significantly inhibited p53 phosphorylation, increased Bcl-2 levels, and reduced subsequent cell death. CIP also elevated p21and Gadd45a levels in both types of irradiated cells. Therefore, these results suggest that CIP may prove to be beneficial as an effective countermeasure for treating critical sequelae associated to radiation in normal healthy cells and cancerous cells.
In conclusion, CIP exerted its actions in normal human blood cells differently from tumor cells. Figure 8 shows a diagram proposing an idea that is very important in radiation-induced cell death. The idea is that acute ionizing irradiation increases c-H2AX formation, p53 phosphorylation, Gadd45a, and p21 in both tumor cells and normal healthy cells. Moreover, radiation increases Bcl-2 levels in normal healthy cells, but does not alter Bcl-2 and Bax levels in tumor cells. CIP inhibits c-H2AX formation and promotes p-53 phosphorylation and inhibits Bcl-2 basal levels to increase cell death in irradiated TK6 cells, while CIP inhibits p53 phosphorylation and increases Bcl-2 production to reduce cell death in normal healthy cells. Despite the need for more evidence, our data are the first to Acute ionizing irradiation increases c-H2AX formation, p53 phosphorylation, Gadd45a, and p21 in both tumor cells and normal healthy cells. Moreover, radiation increases Bcl-2 levels in normal healthy cells, but does not alter Bcl-2 levels in tumor cells. CIP pretreatment inhibits c-H2AX formation and promotes p-53 phosphorylation and inhibits Bcl-2 basal levels to increase cell death in irradiated TK6 cells, while CIP inhibits p53 phosphorylation and increases Bcl-2 production to reduce cell death in normal healthy cells. CIP ciprofloxacin, upwards arrow increase, downwards arrow decrease, horizontal line no change, light down and horizontal line or vertical light and horizontal line or vertical light and horizontal line: inhibition, rightwards arrow stimulation support the idea that CIP displays different actions toward normal human blood cells and tumor cells after irradiation (Fig. 9) .
